KR100911790B1 - 미세화 프로게스테론을 주성분으로 하는 제약 조성물,그의 제조 방법 및 그의 용도 - Google Patents

미세화 프로게스테론을 주성분으로 하는 제약 조성물,그의 제조 방법 및 그의 용도 Download PDF

Info

Publication number
KR100911790B1
KR100911790B1 KR1020047007199A KR20047007199A KR100911790B1 KR 100911790 B1 KR100911790 B1 KR 100911790B1 KR 1020047007199 A KR1020047007199 A KR 1020047007199A KR 20047007199 A KR20047007199 A KR 20047007199A KR 100911790 B1 KR100911790 B1 KR 100911790B1
Authority
KR
South Korea
Prior art keywords
oil
progesterone
pharmaceutical composition
composition according
estradiol
Prior art date
Application number
KR1020047007199A
Other languages
English (en)
Korean (ko)
Other versions
KR20050058231A (ko
Inventor
앙투안느 베신스
제롬 베제
Original Assignee
베신스 인터내셔날 벨기에
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베신스 인터내셔날 벨기에 filed Critical 베신스 인터내셔날 벨기에
Publication of KR20050058231A publication Critical patent/KR20050058231A/ko
Application granted granted Critical
Publication of KR100911790B1 publication Critical patent/KR100911790B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
KR1020047007199A 2001-11-13 2002-11-13 미세화 프로게스테론을 주성분으로 하는 제약 조성물,그의 제조 방법 및 그의 용도 KR100911790B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0114653A FR2832065B1 (fr) 2001-11-13 2001-11-13 Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
FR01/14653 2001-11-13

Publications (2)

Publication Number Publication Date
KR20050058231A KR20050058231A (ko) 2005-06-16
KR100911790B1 true KR100911790B1 (ko) 2009-08-12

Family

ID=8869332

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047007199A KR100911790B1 (ko) 2001-11-13 2002-11-13 미세화 프로게스테론을 주성분으로 하는 제약 조성물,그의 제조 방법 및 그의 용도

Country Status (25)

Country Link
US (5) US20030092691A1 (es)
EP (1) EP1443940B1 (es)
KR (1) KR100911790B1 (es)
CN (1) CN1263453C (es)
AT (1) ATE339958T1 (es)
AU (1) AU2002352334B2 (es)
BR (1) BRPI0214043B8 (es)
CY (1) CY1106293T1 (es)
DE (1) DE60214876T2 (es)
DK (1) DK1443940T3 (es)
EA (1) EA006550B1 (es)
ES (1) ES2272793T3 (es)
FR (1) FR2832065B1 (es)
HK (1) HK1064606A1 (es)
HU (1) HU229341B1 (es)
IL (2) IL161668A0 (es)
MA (1) MA27081A1 (es)
NO (1) NO335044B1 (es)
NZ (1) NZ532659A (es)
OA (1) OA12726A (es)
PL (1) PL206096B1 (es)
PT (1) PT1443940E (es)
UA (1) UA77451C2 (es)
WO (1) WO2003041720A1 (es)
ZA (1) ZA200403288B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832065B1 (fr) 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
CA2533013C (en) * 2003-07-17 2011-07-26 Banner Pharmacaps, Inc. Controlled release preparations
AU2006249349B2 (en) * 2005-05-26 2012-01-12 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
US8828981B2 (en) * 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
EP2055306A1 (de) * 2007-11-05 2009-05-06 Bayer Schering Pharma AG Verwendung eines Gestagens in Kombination mit einem Estrogen und einem oder mehreren pharmazeutisch annehmbaren hilfsstoffen/Trägern zur laktosefreien oralen Kontrazeption
FR2947178B1 (fr) 2009-06-29 2012-07-06 Effik Composition pharmaceutique a base de progesterone micronisee et ses utilisations
CN102091054B (zh) * 2009-12-14 2014-04-16 浙江爱生药业有限公司 黄体酮制剂组合物及其制备方法
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
JP6290081B2 (ja) * 2011-09-15 2018-03-07 フリウルケム、ソシエタ、ペル、アチオニＦｒｉｕｌｃｈｅｍ Ｓｐａ 動物への経口投与用組成物、その製造方法およびその使用
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2016018993A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
MX2017016823A (es) 2015-06-22 2018-03-12 Lipocine Inc Composiciones orales que contienen éster de 17- hydroxiprogesterona y métodos relacionados.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
EP3395332A1 (en) * 2017-04-28 2018-10-31 Chemo Research, S.L. Hormone softgel capsules and a process for the preparation thereof
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2021195319A1 (en) 2020-03-26 2021-09-30 Plx Opco Inc. PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND- METHODS FOR MAKING AND USING SAME

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140021A (en) * 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
IT1256386B (it) * 1992-11-13 1995-12-04 Luigi Boltri Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
ATE150640T1 (de) * 1993-12-22 1997-04-15 Oreal Kosmetisches oder dermatologisches pulver, verfahren zu seiner herstellung und verwendungen
FR2747042B1 (fr) * 1996-04-05 1998-06-05 Besins Iscovesco Lab Medicament a base de progesterone et d'oestradiol
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
ES2152671T3 (es) * 1996-05-01 2001-02-01 Us Gov Health & Human Serv Derivados de progesterona sustituidos en posicion 21 como nuevos agentes antiprogestacionales.
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
FR2832065B1 (fr) 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140021A (en) * 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome

Also Published As

Publication number Publication date
ES2272793T3 (es) 2007-05-01
EA006550B1 (ru) 2006-02-24
NZ532659A (en) 2006-04-28
US20050004076A1 (en) 2005-01-06
HUP0401935A3 (en) 2011-02-28
IL161668A0 (en) 2004-09-27
US20110135719A1 (en) 2011-06-09
UA77451C2 (en) 2006-12-15
EP1443940A1 (fr) 2004-08-11
EP1443940B1 (fr) 2006-09-20
US20090123534A1 (en) 2009-05-14
KR20050058231A (ko) 2005-06-16
IL161668A (en) 2009-09-01
HU229341B1 (en) 2013-11-28
PL206096B1 (pl) 2010-06-30
DE60214876D1 (de) 2006-11-02
CN1585644A (zh) 2005-02-23
FR2832065A1 (fr) 2003-05-16
CN1263453C (zh) 2006-07-12
PL369131A1 (en) 2005-04-18
CY1106293T1 (el) 2011-10-12
HUP0401935A2 (hu) 2005-01-28
US20030092691A1 (en) 2003-05-15
FR2832065B1 (fr) 2004-11-05
NO20042002L (no) 2004-05-14
US8435561B2 (en) 2013-05-07
AU2002352334B2 (en) 2008-10-23
BR0214043A (pt) 2004-10-13
EA200400668A1 (ru) 2004-10-28
ZA200403288B (en) 2005-07-27
HK1064606A1 (es) 2005-02-04
MA27081A1 (fr) 2004-12-20
ATE339958T1 (de) 2006-10-15
US7431941B2 (en) 2008-10-07
OA12726A (en) 2006-06-27
NO335044B1 (no) 2014-09-01
PT1443940E (pt) 2007-01-31
DE60214876T2 (de) 2007-04-05
BRPI0214043B1 (pt) 2019-12-31
US20120276194A1 (en) 2012-11-01
WO2003041720A1 (fr) 2003-05-22
DK1443940T3 (da) 2007-01-29
US7829115B2 (en) 2010-11-09
BRPI0214043B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
KR100911790B1 (ko) 미세화 프로게스테론을 주성분으로 하는 제약 조성물,그의 제조 방법 및 그의 용도
EP1414937B1 (de) Hopfenextrakte, verfahren zu ihrer herstellung und verwendung
JP2656997B2 (ja) ステロールの脂肪酸エステルの抗腫瘍剤のための自発的分散性濃縮物及びそれを含む医薬組成物
US20100330168A1 (en) Pharmaceutical composition based on micronized progesterone and uses thereof
KR20170019448A (ko) 11가지 트리글리세라이드를 포함한 의이인오일, 제제 및 그 응용
JPH05502457A (ja) カバーカバ抽出物、これらの製造プロセスおよび使用
CN105997925A (zh) 丹参酮ⅱa软胶囊及其制备方法
EP2628485B1 (en) New use of chemical ingredients in cynomorium as phytoestrogen
JP4579620B2 (ja) エストロゲン様作用剤及びその製造方法、並びに骨粗しょう症予防剤及び骨粗しょう症治療剤
JP2005139150A (ja) エストロゲン様作用剤及びその製造方法、並びに骨粗しょう症予防剤及び飲食品
CN114522190B (zh) 一种抗心肌缺血损伤的药物组合物及其制备方法和应用
CN101543490A (zh) 染料木素在制备治疗前列腺增生的药物中的应用及产品和制法
KR100618012B1 (ko) 2-메틸-티에노-벤조디아제핀 제제
RU2219904C2 (ru) Вагинальные суппозитории, обладающие противогрибковым действием (варианты)
CN114848650A (zh) 一种稳定的艾司唑仑制剂组合物及其制备方法
JP3987663B2 (ja) 崩壊性を改善した生薬含有組成物
WO2021021032A1 (en) A composition containing cashew leaf extract and production method thereof
CN102743370A (zh) 双醋瑞因的新用途
RO127000A2 (ro) Complex bioactiv de acizi triterpenici, procedeu de obţinere şi produse medicamentoase

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120723

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20130723

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20140724

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20150728

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20160727

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20170724

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20180719

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20190806

Year of fee payment: 11